Discover 483 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 483
Active & Responsive
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
for
PTSD
Location: Grand Rapids MI, Battle Creek MI, Flint MI, Houghton Lake MI,
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05457985
Recruiting
Active & Responsive
Advancing Transplantation Outcomes in Children
for
Kidney Transplant
Location: Grand Rapids MI, Chicago IL, Cincinnati OH, Pittsburgh PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 13 - 20
Code: NCT06055608
Phase2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Grand Rapids MI, Saint Paul MN, Saint Louis Park MN,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
for
Rectal Cancer
Location: Grand Rapids MI, Kalamazoo MI, Jackson MI, Novi MI,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06205485
Phase3, Recruiting
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Grand Rapids MI, Cleveland OH, Cincinnati OH, Iowa City IA,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT05987332
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Grand Rapids MI, Cincinnati OH, Barrie, Toronto, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors